Myostatin, Activin Or Activin Receptor Antagonists For Use In Treating Obesity And Related Conditions - EP3558361
The patent EP3558361 was granted to Novartis on Aug 20, 2025. The application was originally filed on Dec 20, 2017. The patent is currently recorded with a legal status of "Granted".
EP3558361
- Filing Date
- Dec 20, 2017
- Status
- Granted
- Grant Date
- Aug 20, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents